Cigna Evernorth — D&A decreased by 10.8% to $560.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.1%, from $584.00M to $560.00M. Over 4 years (FY 2021 to FY 2025), Evernorth — D&A shows relatively stable performance with a 0.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Stable or predictable levels are expected; significant spikes may indicate large capital investments or asset impairments.
This is the total non-cash expense allocated to the wear and tear of physical assets and the systematic write-down of in...
Standard accounting metric used across all capital-intensive industries.
ci_segment_evernorth_health_services_depreciation_and_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $579.00M | $579.00M | $579.00M | $570.75M | $570.75M | $570.75M | $570.75M | $609.50M | $609.50M | $609.50M | $609.50M | $606.00M | $614.00M | $544.00M | $555.00M | $584.00M | $587.00M | $601.00M | $628.00M | $560.00M |
| QoQ Change | — | +0.0% | +0.0% | -1.4% | +0.0% | +0.0% | +0.0% | +6.8% | +0.0% | +0.0% | +0.0% | -0.6% | +1.3% | -11.4% | +2.0% | +5.2% | +0.5% | +2.4% | +4.5% | -10.8% |
| YoY Change | — | — | — | — | -1.4% | -1.4% | -1.4% | +6.8% | +6.8% | +6.8% | +6.8% | -0.6% | +0.7% | -10.7% | -8.9% | -3.6% | -4.4% | +10.5% | +13.2% | -4.1% |